Research & Development: Page 86
-
PharmaVoice Team/PharmaVoice
On the Calendar
April 15-19 Society for Biomolecular Sciences 13th Annual Conference & Exhibition Palais de Congres de Montreal, Montreal, Canada For more information, contact Marietta Manoni, Society for Biomolecular Sciences, at 203-743-1336, e-mail [email protected], or visit sbsonline.org. April 16-17 ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Patient Eduction Programs to Grow in Use Patient education has a strong perceived value across multiple sectors of the healthcare industry. This value is expected to grow in 2007, according to results of a survey on patient education conducted by HealthEd. Among key findings of the first annual s...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineClinical trial diversity
As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
E-Media
etrials Unveils New Version of EDC Solution etrials Worldwide has unveiled EDC 2.0 solution. Combining more than 10 years of market validation and customer deployments, the newest solution builds upon existing Web-based software as a service (SaaS) solution for collecting, managing, and analyzing...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Making Personalized Medicine Understandable Education is Key As William D. Young, CEO of Monogram Bioscience, states in The Age of Personalized Medicine, (PharmaVOICE February 2007), honestly and clearly addressing the concerns of the stakeholders (drug makers, insurance companies, doctors, and p...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Whether we are discussing clinical studies or creative executions, there is a bit of artistry that is involved in executing the science. This concept is perfectly captured by two of this month’s feature articles. This month’s Forum, which discusses the evolving role of the clinical project manage...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DNA-Based Diagnostics: Testing for Personalized Medicine
By Cynthia Borda Theranostic testing There will come a time when genetic testing will be as common in the physician’s office as a blood pressure reading or the use of an MRI. The pharmaceutical industry is making headway in the personalized medicine arena, and diagnostic companies are actively de...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Nancy Smerkanich The U.S. Food and Drug Administration (FDA) called a Part 15 (21 CFR Part 15) hearing on Dec. 18, 2006, primarily as “a listening exercise” to gather information so that the agency could move forward to “an all electronic submission environment and electronic data ...
By Nancy Smerkanich • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents April 2007 On the Cover The Evolving Role of the Clinical Project Manager Clinical studies have become more complicated, are multinational, and must adhere to a variety of laws and regulations. As a result, the project manager role has become a core capability needed for drug de...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Global Connections
By Taren Grom, Editor Global outsourcing, as it relates to international sponsor/supplier relationships, is constantly changing and growing. Pharmaceutical companies and their partners can gain significant competitive advantages through global outsourcing when sound business practices are applied...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Master Plan: The Making of a Successful Publication Strategy
By Elisabeth Pena Villarroel Publication planning is an essential part of the drug-development process. The results of the long, labor-intensive years of a clinical trial are announced to the industry and medical professionals through publication in medical journals. Preparing trial results for p...
By Elisabeth Pena Villarroel • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A New Era in the Science of Aging
By Cynthia Borda Older Americans face new and growing challenges in managing chronic diseases, which are now the leading causes of death among people older than the age of 65. Every seven seconds someone in the United States is celebrating a 60th birthday. This trend began Jan. 1, 2006, and will ...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Drug Counterfeiting Creates Need for RFID in European Markets The use of radio frequency identification (RFID) by Europe’s pharmaceutical industry continues to be driven by increasing counterfeit products in the market. Such counterfeiting is largely due to deficiencies in the supply chain and th...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
CME: Measuring the Impact
By Denise Myshko Outcomes assessment of continuing education can help determine whether there is a change in participants’ knowledge and performance. March 2007 Barbara Winkelman CME LLC Over time, there is going to be a change in how CME is delivered and how outcomes are measured; there will be ...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Site Value I think most agree the PI/coordinator/patient relationship is key to enrollment and most importantly retention. Therefore PROs should be viewed in the context of their value added to each site that agrees to participate in a study as opposed to being viewed as an added value to the stu...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Movers & Shakers HBA Honorees Woman of the Year, Honorable Mentor, and Star Volunteer Meryl Zausner, VP and CFO of Novartis Oncology, has been named as 2007 Woman of the Year by The Healthcare Businesswomen’s Association. Ms. Zausner was a founding member of the Novartis Oncology global busin...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Leadership development is a concern for all executive management teams, no matter the size of their company or their business model. It’s vitally important to have processes in place that foster talent development for the next generation of leaders. The subject of this month’s Forum had been on t...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
March 15-16 Prescription Drug Pricing InterContinental The Barclay, New York PharmaVOICE subscribers are eligible for a $200 discount; register using priority code 656PHVC. For more information, contact Edward Santelices, American Conference Institute, at 212-352-3220, ext. 239, e-mail e.santelic...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
CommonHealth Celebrates Opening Of Paris Office The move is designed to allow CommonHealth to broaden its offerings to an increasingly global clientele. CommonHealth has opened an office in Paris. The move is designed to allow CommonHealth to broaden its offerings to an increasingly global client...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
Thomson Scientific Expands Pharmaceutical Regulatory Intelligence Coverage Thomson Scientific announces that three new country modules, India, Israel, and Turkey, are now available in IDRAC, the global pharmaceutical regulatory intelligence database. IDRAC is recognized by regulatory professional...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Dr. Lou Barbato Tikvah Names VP, Clinical R&D, and Chief Medical Officer Atlanta-based Tikvah Therapeutics has named Lou Barbato, M.D., as VP, clinical research and development, and chief medical officer. Tikvah acquires, develops, and commercializes novel therapeutics related to ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Moving Science Forward -- Dr. Russell M. Medford
By Kim Ribbink With a pioneering spirit that has led him to tackle emerging fields of science, Russell M. Medford, M.D., Ph.D., is striving to ensure that AtheroGenics, the company he cofounded in 1993, is creating breakthrough medications for chronic inflammation. March 2007 Entrepreneurial spir...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
EDC: Crossing the Chasm
In the figurative but practical language of Silicon Valley marketing guru Geoffrey Moore, the leading EDC companies have “crossed the chasm” from the fluidity of the early adopter market to the more established needs of the mainstream market. This may be the dream of many an EDC company CEO, but ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Overcoming Challenges to the Path to Combination Product Development Combination products have the potential to vastly improve medical care, making treatment more effective and safe, as well as improving compliance for patients. But because of the novelty and complexity of such products, companie...
By Christine Ford • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents March 2007 On the Cover Leadership Development: The Next Generation Industry leaders have to manage a complex and evolving environment. A company’s success will depend on its ability to identify and develop these executives. Features The Making of a Successful Publication Strate...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Looking Ahead: The Deficit Reduction Act
A prescription to adopt forward-looking strategies and ensure corporate and regulatory compliance excellence As government healthcare spending increases, Congress, states, and agencies will continue to put cost management and containment on their agendas. Given this reality, it is important to bu...
By PharmaVoice Team • Jan. 2, 2008
Previous
